FDA Inspection 1285158 — Eurofins BioPharma Product Testing Spain SLU
The FDA completed an inspection of Eurofins BioPharma Product Testing Spain SLU on Jan 13, 2022 in Esplugues De Llobregat. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 13, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Esplugues De Llobregat (Spain)
Additional Details
Mutual Recognition Agreement (MRA)